Therapeutic interventions in sepsis: current and anticipated pharmacological agents - Wikidata - awgldk - TriplyDB

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

http://www.wikidata.org/entity/Q34427050

about

Melatonin Supplementation, a Strategy to Prevent Neurological Diseases through Maintaining Integrity of Blood Brain Barrier in Old People.Melatonin alleviates lipopolysaccharide-compromised integrity of blood-brain barrier through activating AMP-activated protein kinase in old mice.Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward?Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways.Nuclear histones: major virulence factors or just additional early sepsis markers? A comment.

P2860

Q33720530-A0868D60-D49D-4F8E-9F02-88AB22B18B91 Q37678194-E0034DA1-137C-4F5D-A2B1-6F6609505675 Q38669814-8F1C9453-DCBD-48E7-8719-5E3DBA923D03 Q38758754-F3D87F63-0E2F-46CE-B984-BBF7288AA5C5 Q38822661-724D16ED-0D1A-48AF-88E0-44323248946D

P2860

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

http://www.wikidata.org/entity/Q34427050

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@ast

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@en

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@nl

type

label

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@ast

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@en

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@nl

prefLabel

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@ast

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@en

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@nl

P1433

Q34427050-B7C05F9D-3DA0-4CA9-AD8E-BF11048FF095

P1476

Q34427050-CE00461F-B412-48C2-8249-8845F3FDF1C7

P2093

Q34427050-61144DE5-4961-40D0-ABAC-2943BECBBE31

Q34427050-61B7EAB7-AA4E-43F5-ADB9-16D9150264F9

Q34427050-A62D47E8-E228-4309-BFD9-831A6FE3AE5D

Q34427050-DB3BE2E8-C344-49E8-B592-26AED7D2ED50

Q34427050-DF35D936-312A-4587-9714-80E9ABE4985D

Q34427050-E17970C9-0D66-432D-B149-1037DDE4F0D2

P2860

Q34427050-073D622A-ABAB-4134-913D-6999855D8D47

Q34427050-08453C45-E30B-4003-A1DF-8BE289600E06

Q34427050-090275EA-483F-43A6-A011-28D39870329C

Q34427050-09502365-72CC-4006-9305-362560B0321E

Q34427050-0A5E96AF-5ACD-47AA-82C3-D7C89C975AE7

Q34427050-0D0DF779-7498-493D-8CE4-933C6532DAFC

Q34427050-0D2F26D0-97DB-4AF4-9380-BE1932987F14

Q34427050-0E22BA42-E4A4-466A-A1FB-07B1DA665D28

Q34427050-0F4814B0-A3BC-451B-8805-D159B3B4DBEF

Q34427050-116FD856-96BF-4D01-BEA5-AB9EEF178AA7

P304

Q34427050-DB4B7D81-5A69-4B02-A863-98D38523D1B6

P31

Q34427050-F547FFA4-D14F-4A06-9A5A-1694B16E1F5E

P356

Q34427050-87C4CCDB-B1FB-4992-BFE9-94BE3C7BD66A

P407

Q34427050-A24642E6-296F-4CAF-A205-989C96A831F0

P433

Q34427050-665C8679-8D5F-4975-BDA1-52AF0F9280BE

P478

Q34427050-66FEA53A-3AE2-4700-BEED-385E53CAA0AE

P50

Q34427050-AAB2DC4B-CE90-4444-96F5-0B22742FFC22

P577

Q34427050-3E4FBE77-12EB-4BF6-9556-2363FF5E4CD8

P5875

Q34427050-C57FA1F4-63E3-41FC-9CC1-D0532CA5E884

P698

Q34427050-FD27A1C3-36A3-405D-83A8-9A99A2AD9490

P921

Q34427050-A79BA835-838F-48AA-80F0-C0902CC56E29

P932

Q34427050-A52ACF20-5637-4B38-B281-68B791CF4820

P356

P1433

British Journal of Pharmacology

P1476

Therapeutic interventions in sepsis: current and anticipated pharmacological agents

@en

P2093

G Madhava Rao

http://www.w3.org/2001/XMLSchema#string

Gitu Pandey

http://www.w3.org/2001/XMLSchema#string

Naresh Mittapelly

http://www.w3.org/2001/XMLSchema#string

Prabhat Ranjan Mishra

http://www.w3.org/2001/XMLSchema#string

Ranjita Shegokar

http://www.w3.org/2001/XMLSchema#string

Shweta Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

The microcirculation is the motor of sepsis

The role of complement system in septic shock

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Macrophage migration inhibitory factor: a regulator of innate immunity

Polyketal microparticles: a new delivery vehicle for superoxide dismutase

Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release

A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats

Efficacy and safety of recombinant human activated protein C for severe sepsis

Nanocarriers as an emerging platform for cancer therapy

P304

5011-5031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.12829

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Prashant Shukla

P577

2014-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263583672

http://www.w3.org/2001/XMLSchema#string

P698

24977655

http://www.w3.org/2001/XMLSchema#string

P921

P932

4253453

http://www.w3.org/2001/XMLSchema#string